Recent Updates
Recently added Catalysts
ATEC Neutral Sentiment Score: 60/100

ATEC Announces Proposed Public Offering of Common Stock

Key Takeaway: Alphatec Holdings, Inc. (ATEC) has announced a proposed public offering of $150 million in common stock, with an option for underwriters to purchase an additional $22.5 million. The offering is contingent on market conditions and is being managed by investment firms including Stanley, TD Cowen, Barclays, and Stifel. ATEC emphasizes that the offering is made under the stipulations of a previously filed shelf registration statement and provides detailed instructions for obtaining the prospectus. The company continues to focus on advancing spine surgery technologies through its subsidiaries and innovative solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • ATEC is initiating a public offering of $150 million, which indicates investor interest.
  • The offering includes a potential additional purchase of $22.5 million by underwriters, showing confidence in the stock’s value.
  • ATEC's innovative approach to spine surgery may attract further investments.

CONCERNS & RISKS

  • The offering is subject to market and other conditions, adding uncertainty to its completion.
  • No assurance can be given that the offering will complete on schedule, posing a risk to capital acquisition.

Full Press Release Details

ATEC Announces Proposed Public Offering of Common Stock
CARLSBAD, California, October 24, 2023 Alphatec Holdings, Inc. ( ATEC ) (NASDAQ: ATEC), a provider of innovative
solutions dedicated to revolutionizing the approach to spine surgery, today announced that it has commenced a proposed underwritten public offering of $150 million of shares of its common stock. In connection with the proposed offering, ATEC
intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock sold in the offering. All of the shares in the offering are to be sold by
ATEC. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.
Stanley, TD Cowen, Barclays and Stifel are acting as joint book-running managers in the offering.
The shares of common stock are being offered pursuant
to a shelf registration statement on Form S-3 (File No. 333-271336) previously filed with and declared effective by the Securities and Exchange Commission (the
SEC ). The offering will be made only by means of a written prospectus and prospectus supplement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on
the SEC s website at www.sec.gov.
When available, copies of the preliminary prospectus supplement and accompanying prospectus may also be obtained
from Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; Cowen and Company, LLC, 599 Lexington Avenue, New York, New York 10022, by telephone at (833)
297-2926 or by email at prospectus_ecm@cowen.com; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone at
1-888-603-5847 or by email at barclaysprospectus@broadridge.com.
This press release shall not constitute an offer to sell nor the solicitation of an offer to buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering may only be made by means of a prospectus supplement and
related base prospectus.
ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to
revolutionizing the approach to spine surgery through clinical distinction. ATEC s Organic Innovation Machine is focused on developing new approaches that integrate seamlessly with the
Company s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC s vision is to be the Standard Bearer in Spine.
Forward-Looking Statements
This press release contains
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management s current expectations and are subject to a number of
risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. ATEC cautions investors that there can be no assurance that actual results or business conditions will not differ
materially from those projected or suggested in such forward-looking statements as a result of various factors. The words believe, will, should, expect, intend, estimate,
look forward and anticipate, variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. Forward-looking
statements include, but are not limited to, the Company s expectations regarding the completion, timing and size of the proposed public offering. Important factors that could cause actual results to differ significantly from those expressed or
implied by such forward-looking statements include, but are not limited to, risks and uncertainties related to market and other conditions and the satisfaction of customary closing conditions related to the proposed public offering. A further
list and description of these and other factors, risks and uncertainties can be found in ATEC s most recent annual report, any subsequent quarterly and current reports, and certain other filings, filed with the SEC. ATEC disclaims any intention
or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
Chief Financial Officer
Investor/Media Contact:
investorrelations @atecspine.com

Frequently Asked Questions

What is the proposed amount for ATEC's public offering?

ATEC has announced a proposed public offering of $150 million.

Who is managing ATEC's public stock offering?

Stanley, TD Cowen, Barclays, and Stifel are the joint book-running managers.

Where can I find ATEC's preliminary prospectus?

The preliminary prospectus will be available on the SEC's website.

Are the shares in the offering being sold by ATEC?

Yes, all shares in the offering are to be sold by ATEC.

What is ATEC's vision in spine surgery?

ATEC aims to be the Standard Bearer in spine surgery.

Last updated: Oct 24, 2023